SciBac Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 4

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $287K

  • Investors
  • 8

SciBac General Information

Description

Developer of novel biotherapeutics designed to treat antibiotic-resistant diseases while fortifying the microbiome. The company's biotherapeutics improve beneficial microorganisms using technology to naturally, and safely transfer useful genetic traits and use a type of directed evolution to increase therapeutic efficacy and targets a specific disease through multiple modes of action, enabling medical practitioners to enhance the microbiome for fast recovery and reduce the risk of reinfections.

Contact Information

Website
www.scibac.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1828 El Camino Real
  • Suite 402
  • Burlingame, CA 94010
  • United States
+1 (650) 000-0000

SciBac Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SciBac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 09-Jul-2019 $287K 00.000 Completed Generating Revenue
7. Early Stage VC 07-Jan-2019 00000 00.000 Completed Generating Revenue
6. Grant 20-Jul-2018 00.000 00000 Completed Generating Revenue
5. Early Stage VC 20-Mar-2018 00000 00000 Completed Generating Revenue
4. Grant 01-Apr-2017 00000 Completed Generating Revenue
3. Accelerator/Incubator 04-Apr-2016 Completed Generating Revenue
2. Early Stage VC 01-Apr-2016 $450K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
To view SciBac’s complete valuation and funding history, request access »

SciBac Patents

SciBac Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3116559-A1 Live biotherapeutics to treat and prevent lung conditions Pending 17-Oct-2018 0000000000
US-20210353693-A1 Live biotherapeutics to treat and prevent lung conditions Pending 17-Oct-2018 0000000000
JP-2022505421-A Live biopharmacy for treating and preventing pulmonary disease Pending 17-Oct-2018 0000000000
EP-3866820-A2 Live biotherapeutics to treat and prevent lung conditions Pending 17-Oct-2018 0000000000
AU-2019361036-A1 Live biotherapeutics to treat and prevent lung conditions Pending 17-Oct-2018 A61K35/747
To view SciBac’s complete patent history, request access »

SciBac Executive Team (4)

Name Title Board Seat Contact Info
Jeanette Mucha Co-Founder, Chief Executive Officer, Chief Science Officer, President and Board Member
Derik Twomey Co-Founder, Chief Operating Officer & Board Member
Anthony Cann Ph.D Co-Founder, Chief Technology Officer & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

SciBac Board Members (3)

Name Representing Role Since
Anthony Cann Ph.D SciBac Co-Founder, Chief Technology Officer & Board Member 000 0000
Derik Twomey SciBac Co-Founder, Chief Operating Officer & Board Member 000 0000
Jeanette Mucha SciBac Co-Founder, Chief Executive Officer, Chief Science Officer, President and Board Member 000 0000
To view SciBac’s complete board members history, request access »

SciBac Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SciBac Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Lagomaj Capital Venture Capital Minority 000 0000 000000 0
Tillman Venture Partners Venture Capital Minority 000 0000 000000 0
CARB-X University 000 0000 000000 0
Breakout Labs Not-For-Profit Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »